superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2017-12-31
- Valid until
- 2018-12-31
- Published
- 2018-02-08
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 2,534,400,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals operating income: 2,079,591,000 United States dollar", as of 2017-12-31 (until 2018-12-31). Claim clm_C3B4B1FC7983, https://asof.is/claim/clm_C3B4B1FC7983, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm.
APA
AsOf. (2017). Regeneron Pharmaceuticals operating income: 2,079,591,000 United States dollar (as of 2017-12-31 (until 2018-12-31)) [Record clm_C3B4B1FC7983]. Retrieved November 9, 2026, from https://asof.is/claim/clm_C3B4B1FC7983 (source: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm)
BibTeX
@misc{asof_clm_C3B4B1FC7983,
author = {AsOf},
title = {Regeneron Pharmaceuticals operating income: 2,079,591,000 United States dollar},
year = {2017},
howpublished = {\url{https://asof.is/claim/clm_C3B4B1FC7983}},
note = {Claim clm\_C3B4B1FC7983, as of 2017-12-31 (until 2018-12-31); source: https://www.sec.gov/Archives/edgar/data/872589/000153217618000013/0001532176-18-000013-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_C3B4B1FC7983.md/v1/claims/clm_C3B4B1FC7983submit a correction